| Prostate Cancer Clinical Outcomes |
K.C Balaji |
UF Health Jacksonville |
PLCO |
Jan 3, 2023 |
PLCO-1139 |
| Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer |
Konrad Stopsack |
Harvard T.H. Chan School of Public Health |
PLCO |
Sep 9, 2022 |
PLCO-1046 |
| “Prostate cancer data analysis using machine learning methods” |
Henry Barlow |
The University of Sydney |
PLCO |
Apr 5, 2019 |
PLCO-468 |
| Prostate Cancer Detection with Negative PSA Screening Exams |
Richard Hayes |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0131 |
| Prostate Cancer Dietary Factors - Antioxidative Vitamins, Dietary Supplements |
Victoria Kirsh |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0009 |
| Prostate Cancer Dietary Factors - Dietary Patterns |
Jiyoung Ahn |
NCI, DCEG, NEB |
PLCO |
Jul 1, 2006 |
2006-0266 |
| Prostate Cancer Dietary Factors - Fruits and Vegetables, Lycopene |
Victoria Kirsh |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0008 |
| Prostate Cancer Dietary factors - Glycemic Factors/Inflammatory Factors |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0147 |
| Prostate Cancer Dietary Factors - Meat Related Mutagens (Heterocyclic amines in meat cooked at high temperature and prostate cancer ) |
Amanda Cross |
NCI, DCEG, NEB |
PLCO |
Jul 1, 2006 |
2006-0066 |
| Prostate Cancer, Insulin Resistance and Obesity: Biochemistry and Genetics |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0146 |
| Prostate Cancer Other Factors-Family History |
Juan Alguacil |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0026 |
| Prostate Cancer Other Factors-NSAIDs |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Jul 1, 2006 |
2006-0223 |
| Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) |
Ann Hsing |
NCI, DCEG, HREB |
PLCO |
Mar 25, 2011 |
2011-0053 |
| Prostate cancer risk prediction using clinical risk factors and genetics |
Nathan White |
Multimodal Imaging Services Corporation, dba HealthLytix |
PLCO |
Jan 30, 2020 |
PLCO-574 |
| Prostate Cancer Survival in PLCO: The effect of screening |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Mar 3, 2011 |
2010-0301 |
| Prostate cancer treatment choices in PLCO |
Robert Grubb |
Washington University School of Medicine in St. Louis |
PLCO |
Mar 20, 2008 |
2008-0008 |
| Prostate dataset evaluation |
Timothy Wong |
Independent |
PLCO |
Oct 5, 2017 |
PLCO-316 |
| Prostate Specific Antigen (PSA) Growth Curves: an Innovation to Improve Prostate Cancer Screening |
James Hebert |
University of South Carolina, Cancer Prevention and Control Program |
PLCO |
Feb 22, 2013 |
PLCO-15 |
| Prostate-specific antigen screening rates and factors associated with screening in American men |
Ming Liu |
Beijing Hospital |
PLCO |
Apr 16, 2020 |
PLCO-606 |
| Prostate specific antigen volatility and the diagnosis of clinically significant prostate cancer |
John Leppert |
Stanford University |
PLCO |
Aug 29, 2022 |
PLCO-1034 |
